Circadian regulation of mouse topoisomerase I gene expression by glucocorticoid hormones

Biochemical Pharmacology

Volumn 71, Issue 8, 2006, Pages 1155-1161

  Kuramoto, Yukako ^a   Hata, Koujirou ^a   Koyanagi, Satoru ^b   Ohdo, Shigehiro ^b   Shimeno, Hiroshi ^a   Soeda, Shinji ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Adrenalectomy; Chronopharmacotherapy; Circadian rhythm; Corticosterone; CPT 11; Topoisomerase I

Indexed keywords

CAMPTOTHECIN; CORTICOSTERONE; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ANTAGONIST; IRINOTECAN; MESSENGER RNA; MIFEPRISTONE;

ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; GENE EXPRESSION; LIVER; MALE; MOUSE; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR CELL;

ADRENALECTOMY; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE, TUMOR; CIRCADIAN RHYTHM; DNA TOPOISOMERASES, TYPE I; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOCORTICOIDS; MALE; MICE; MICE, INBRED ICR; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECEPTORS, GLUCOCORTICOID;

EID: 33644832775     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.12.034     Document Type: Article

References (19)

1. F. Levi, C. Horvath, M. Mechkouri, A. Roulon, F. Bailleul, and G. Lemaigre Circadian time dependence of murine tolerance for the alkylating agent peptichemio Eur J Cancer Clin Oncol 23 1987 487 497
2. M. Middeke, M. Kluglich, and H. Holzgreve Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: morning versus evening dosing Chronobiol Int 8 1991 506 510
3. S. Koyanagi, S. Ohdo, E. Yukawa, and S. Higuchi Chronopharmacological study of interferon-alpha in mice J Pharmacol Exp Ther 283 1997 259 264
4. Y. Kawato, T. Furuta, M. Aonuma, M. Yasuoka, T. Yokokura, and K. Matsumoto Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice Cancer Chemother Pharmacol 28 1991 192 198
5. A. Kojima, T. Shinkai, and N. Saijo Cytogenetic effects of CPT-11 and its active metabolite, SN-38 on human lymphocytes Jpn J Clin Oncol 23 1993 116 122
6. J.A. Conti, N.E. Kemeny, L.B. Saltz, Y. Huang, W.P. Tong, and T.C. Chou Irinotecan is an active agent in untreated patients with metastatic colorectal cancer J Clin Oncol 14 1996 709 715
7. E. Filipski, G. Lemaigre, X.H. Liu, D. Mery-Mignard, M. Mahjoubi, and F. Levi Circadian rhythm of irinotecan tolerability in mice Chronobiol Int 21 2004 613 630
8. G.A. Goodlad, and Cm. Clark Glucocorticoid-induced changes in liver: effect of dexamethasone administration on DNA topoisomerase I and II activities and distribution of histone H1 subtypes Cell Biochem Funct 12 1994 247 253
9. J.C. Gonzalez, D.C. Johnson, D.C. Morrison, M.A. Freudenberg, C. Galanos, and R. Silverstein Endogenous and exogenous glucocorticoids have different roles in modulating endotoxin lethality in d-galactosamine-sensitized mice Infect Immun 61 1993 970 974
10. D.F. Birt, E. Duysen, W. Wang, and A. Yaktine Corticosterone supplementation reduced selective protein kinase C isoform expression in the epidermis of adrenalectomized mice Cancer Epidemiol Biomarkers Prev 10 2001 679 685
11. A. Kier, J. Han, and L. Jacobson Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression Endocrinology 146 2005 1338 1347
12. N. Gekakis, D. Staknis, H.B. Nguyen, F.C. Davis, L.D. Wilsbacher, and D.P. King Role of the CLOCK protein in the mammalian circadian mechanism Science 280 1998 1564 1569
13. R. Silver, J. LeSauter, P.A. Tresco, and M.N. Lehman A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms Nature 382 1996 810 813
14. A. Balsalobre, F. Damiola, and U. Schibler A serum shock induces circadian gene expression in mammalian tissue culture cells Cell 93 1998 929 937
15. P.J. Houghton, P.J. Cheshire, L. Myers, C.F. Stewart, T.W. Synold, and J.A. Houghton Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors Cancer Chemother Pharmacol 31 1992 229 239
16. S.H. Kaufmann, P.A. Svingen, S.D. Gore, D.K. Armstrong, Y.C. Cheng, and E.K. Rowinsky Altered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells Blood 89 1997 2098 2104
17. Y. Kanemura, H. Mori, S. Kobayashi, O. Islam, E. Kodama, and A. Yamamoto Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity J Neurosci Res 69 2002 869 879
18. L. Calvet, A. Santos, A. Valent, M.J. Terrier-Lacombe, P. Opolon, and J.L. Merlin No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan Br J Cancer 91 2004 1205 1212
19. S. Ohdo, T. Makinosumi, T. Ishizaki, E. Yukawa, S. Higuchi, and S. Nakano Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice J Pharmacol Exp Ther 283 1997 1383 1388